Abstract
Get full access to this article
View all access options for this article.
References
1.
Urnov
F
.
We can cure disease by editing a Person's
DNA
. Why aren't we? The New York Times. December 9, 2022. https://www.nytimes.com/2022/12/09/opinion/crispr-gene-editing-cures.html (last accessed
December 16 , 2022
).
2.
Ferring Pharmaceuticals. Ferring Receives Approval from U.S. FDA for Adstiladrin for High-Risk BC. G-Unresponsive Non-Muscle Invasive Bladder Cancer. December 16, 2022. https://www.ferring.com/ferring-receives-approval-from-u-s-fda-for-adstiladrin-for-high-risk-bcg-unresponsive-non-muscle-invasive-bladder-cancer/ (last accessed
December 16 , 2022
).
3.CSL . U.S. Food and Drug Administration approves CSL's HEMGENIX® (etranacogene dezaparvovec-drlb), the first gene therapy for hemophilia B. November 22, 2022. https://www.csl.com/news/2022/fda-hemgenix (last accessed
December 16 , 2022
).
4.
Bluebird Bio. Bluebird bio Sells Priority Review Voucher for $102 Million. November 30, 2022. https://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-sells-priority-review-voucher-102-million (last accessed
December 16 , 2022
).
5.
iECURE. iECURE Raises $65 Million to Advance In Vivo Gene Editing Programs for the Treatment of Rare Pediatric Liver Diseases. November 30, 2022. https://iecure.com/news/iecure-raises-65-million-to-advance-in-vivo-gene-editing-programs-for-the-treatment-of-rare-pediatric-liver-diseases/ (last accessed
December 16 , 2022
).
6.
SonaThera. SonoThera™ Completes $60.75M Series A Funding for Ultrasound-Guided. Nonviral Gene Therapy Platform Development. December 5, 2022. https://sonothera.com/sonothera-completes-60-75m-series-a-funding-for-ultrasound-guided-nonviral-gene-therapy-platform-development/ (last accessed
December 16 , 2022
).
7.
Editas Medicine. Editas Medicine Announces Positive Safety and Efficacy Data from the First Two Patients Treated in the RUBY Trial of EDIT-301 for the Treatment of Severe Sickle Cell Disease. December 6, 2022. https://ir.editasmedicine.com/news-releases/news-release-details/editas-medicine-announces-positive-safety-and-efficacy-data (last accessed
December 16 , 2022
).